See the DrugPatentWatch profile for yervoy
Yervoy Discount Terms: Understanding the Cost-Saving Options for Ipilimumab
H1: Introduction to Yervoy and Its High Cost
Ipilimumab, marketed under the brand name Yervoy, is a revolutionary immunotherapy medication used to treat various types of cancer, including melanoma, lung cancer, and kidney cancer. Developed by Bristol-Myers Squibb (BMS), Yervoy has been a game-changer in the field of oncology, offering patients a new hope for survival. However, the high cost of Yervoy has been a significant concern for many patients and healthcare providers.
H2: The High Cost of Yervoy
According to a report by DrugPatentWatch.com, the average wholesale price (AWP) of Yervoy in the United States is around $120,000 per year for a single patient. This exorbitant price has made Yervoy inaccessible to many patients who cannot afford it, despite its life-saving potential.
H3: The Need for Discount Terms
In response to the high cost of Yervoy, BMS has introduced various discount terms to make the medication more affordable for patients. These discount terms aim to reduce the financial burden on patients and their families, ensuring that they can access the treatment they need.
H2: Yervoy Discount Terms: What Are They?
BMS offers several discount terms for Yervoy, including:
* Patient Assistance Program (PAP): This program provides eligible patients with a discounted price for Yervoy, making it more affordable for them to access the treatment.
* Co-pay Card Program: This program helps patients with commercial insurance plans pay for Yervoy by covering a portion of their out-of-pocket costs.
* Free Trial Program: This program offers eligible patients a free trial of Yervoy for a limited period, allowing them to assess the treatment's effectiveness before committing to ongoing therapy.
H3: Eligibility Criteria for Yervoy Discount Terms
To be eligible for Yervoy discount terms, patients must meet certain criteria, including:
* Diagnosis: Patients must have a confirmed diagnosis of melanoma, lung cancer, or kidney cancer.
* Insurance Status: Patients must have commercial insurance or be uninsured.
* Income Level: Patients must meet certain income requirements to be eligible for the PAP.
* Other Criteria: Patients may be required to meet additional criteria, such as having a certain level of disease progression or having tried other treatments.
H2: How to Apply for Yervoy Discount Terms
Patients can apply for Yervoy discount terms through various channels, including:
* BMS Website: Patients can visit the BMS website to learn more about the discount terms and apply online.
* Patient Assistance Programs: Patients can contact the PAP directly to apply for assistance.
* Pharmacies: Patients can also contact their pharmacies to learn more about the discount terms and apply in person.
H3: Benefits of Yervoy Discount Terms
The benefits of Yervoy discount terms are numerous, including:
* Reduced Out-of-Pocket Costs: Patients can save thousands of dollars on their out-of-pocket costs for Yervoy.
* Increased Access: Discount terms can make Yervoy more accessible to patients who cannot afford it otherwise.
* Improved Patient Outcomes: By increasing access to Yervoy, discount terms can lead to improved patient outcomes and better survival rates.
H2: Conclusion
Yervoy discount terms offer patients a lifeline in accessing this life-saving medication. By understanding the eligibility criteria and application process, patients can take advantage of these discount terms and make Yervoy more affordable. As the cost of cancer treatment continues to rise, it is essential to explore all available options for reducing the financial burden on patients and their families.
H3: Key Takeaways
* Yervoy discount terms are available to eligible patients through the Patient Assistance Program, Co-pay Card Program, and Free Trial Program.
* Patients must meet certain criteria, including diagnosis, insurance status, income level, and other requirements.
* Patients can apply for Yervoy discount terms through the BMS website, PAP, or pharmacies.
* Discount terms can reduce out-of-pocket costs, increase access, and improve patient outcomes.
H4: FAQs
1. Q: What is the average wholesale price of Yervoy?
A: The average wholesale price of Yervoy is around $120,000 per year for a single patient.
2. Q: What are the eligibility criteria for Yervoy discount terms?
A: Patients must have a confirmed diagnosis of melanoma, lung cancer, or kidney cancer, commercial insurance or be uninsured, meet income requirements, and meet other criteria.
3. Q: How do I apply for Yervoy discount terms?
A: Patients can apply through the BMS website, PAP, or pharmacies.
4. Q: What are the benefits of Yervoy discount terms?
A: Discount terms can reduce out-of-pocket costs, increase access, and improve patient outcomes.
5. Q: Are Yervoy discount terms available for all patients?
A: No, Yervoy discount terms are only available to eligible patients who meet the specified criteria.
Cited Sources:
1. DrugPatentWatch.com. (2022). Ipilimumab (Yervoy) Patent Expiration Date. Retrieved from <https://www.drugpatentwatch.com/patent/US-20120096942>
2. Bristol-Myers Squibb. (2022). Yervoy (Ipilimumab) Patient Assistance Program. Retrieved from <https://www.bms.com/our-company/patient-assistance-program.html>
3. National Cancer Institute. (2022). Ipilimumab. Retrieved from <https://www.cancer.gov/about-cancer/treatment/drugs/ipilimumab>